[Clinical evaluation of the action of Lysocorticone associated with Lysoarthrosis].
D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001920:Bradykinin / Q000037:antagonists & inhibitors*; D002574:Cervical Vertebrae; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D007592:Joint Diseases / Q000188:drug therapy*; D007719:Knee Joint; D008159:Lumbar Vertebrae; D008297:Male; D008875:Middle Aged; D010455:Peptides / Q000627:therapeutic use*; D012702:Serotonin Antagonists; D012785:Shoulder Joint; D013122:Spinal Diseases / Q000188:drug therapy*; D014803:Vitamin B Complex / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D010455:Peptides; D012702:Serotonin Antagonists; D014803:Vitamin B Complex; D001920:Bradykinin
Valutazione clinica dell'attivitá del lysocorticone associato al lysoartrosi.